Dymista nasal spray launched
Date: 08 May 2017

Papaloisou is introducing Dymista nasal spray for the relief of symptoms of moderate to severe seasonal and perennial allergic rhinitis if monotherapy with either intranasal antihistamine or glucocorticoid is not considered sufficient. Dymista contains azelastine hydrochloride (antihistamine) and fluticasone propionate (glucocorticoid) in combination. Dymista is a product of Meda AB.

For more information about Dymista please click here.